Endothelial nitric oxide synthase gene polymorphisms and the risk of silent brain infarction

International Journal of Molecular Medicine

Volumn 25, Issue 5, 2010, Pages 819-823

  Song, Jihwan ^a   Kim, Ok Joon ^a   Kim, Hyun Sook ^a   Bae, Su Jin ^a   Hong, Sun Pyo ^b   Oh, Doyeun ^a   Kim, Nam Keun ^a  

^a CHA University   (South Korea)

^b GeneMatrix Inc   (South Korea)

Author keywords

Endothelial nitric oxide synthase; Haplotype; Polymorphism; Risk factors; Silent brain infarction

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR;

AGED; BRAIN INFARCTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 77951723231     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000410     Document Type: Article

References (29)

1. Kase CS, Wolf PA, Chodosh EH, Zacker HB, Kelly-Hayes M, Kannel WB, D'Agostino RB and Scampini L: Prevalence of silent stroke in patients presenting with initial stroke: the Farmingham study. Stroke 20: 850-852, 1989. (Pubitemid 19188237)
2. Jorgensen HS, Nakayama H, Raaschou HO, Gam J and Olsen TS: Silent infarction in acute stroke patients. Prevalence, localization, risk factors, and clinical significance: the Copenhagen stroke study. Stroke 25: 97-104, 1994. (Pubitemid 24338395)
3. Lee SC, Park SJ, Ki HK, Gwon HC, Chung CS, Byun HS, Shin KJ, Shin MH and Lee WR: Prevalence and risk factors of cerebral infarction in apparently normal adults. Hypertension 36: 73-77, 2000.
4. Corea F, Henon H, Pasquier F and Leys D: Silent infarcts in stroke patients: patient characteristics and effect on 2-year outcome. J Neurol 248: 271-278, 2001. (Pubitemid 32323864)
5. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A and Breteler MMB: Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam scan study. Stroke 33: 21-25, 2002. (Pubitemid 34052178)
6. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ and Breteler MM: Silent brain infarcts and white matter lesions increase stroke risk in the general population. The Rotterdam study. Stroke 34: 1126-1129, 2003.
7. Matsui T, Arai H, Yuzuriha T, Yao H, Miura M, Hashimoto S, Higuchi S, Matsushita S, Morikawa M, Kato A and Sasaki H: Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke 32: 1116-1119, 2001. (Pubitemid 32825794)
8. Kim NK, Choi BO, Jung WS, Choi YJ and Choi KG: Hyperhomocysteinemia as an independent risk factor for silent brain infarction. Neurology 61: 1595-1599, 2003. (Pubitemid 37505585)
9. Eguchi K, Kario K, Hoshide S, Hoshide Y, Ishikawa J, Morinari M, Hashimoto T and Shimada K: Smoking is associated with silent cerebrovascular disease in a high-risk Japanese community-dwelling population. Hypertens Res 27: 747-754, 2004. (Pubitemid 40045514)
10. Kwon HM, Kim BJ, Lee SH, Choi SH, Oh BH and Yoon BW: Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke 37: 466-470, 2006.
11. Garg UC and Hassid A: Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989.
12. Kubes P, Suzuki M and Granger DN: Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651-4655, 1991. (Pubitemid 21914599)
13. Wolf A, Zalpour C, Theilmeier G, Wang BY, Ma A, Anderson B, Tsao PS and Cooke JP: Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol 29: 479-485, 1997. (Pubitemid 27116086)
14. Hassan A, Gormley K, O'Sullivan M, Knight J, Sham P, Vallance P, Bamford J and Markus H: Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 35: 654-659, 2004. (Pubitemid 38280836)
15. Fatini C, Sofi F, Sticchi E, Gensini F, Gori AM, Fedi S, Lapini I, Rostagno C, Comeglio M, Brogi D, Gensini G and Abbate R: Influence of endothelial nitric oxide synthase gene polymorphisms (894G>T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J 147: 516-521, 2004. (Pubitemid 38880876)
16. Elbaz A, Poirier O, Moulin T, Chédru F, Cambien F and Amarenco P: Association between the Glu298Asp polymorphism in the endothelial constitutive nitric oxide synthase gene and brain infarction. The GENIC Investigators. Stroke 31: 1634-1639, 2000. (Pubitemid 30437515)
17. Ozüm U, Bolat N, Gül E and Ozdemir O: Endothelial nitric oxide synthase gene [G894T] polymorphism as a possible risk factor in aneurysmal subarachnoid haemorrhage. Acta Neurochir 150: 57-61, 2008.
18. Chen Y, Huang H, Zhou J, Doumatey A, Lashley K, Chen G, Agyenim-Boateng K, Eghan BA, Acheampong J, Fasanmade O, Johnson T, Akinsola FB, Okafor G, Oli J, Ezepue F, Amoah A, Akafo S, Adeyemo A and Rotimi CN: Polymorphism of the endothelial nitric oxide synthase gene is associated with diabetic retinopathy in a cohort of West Africans. Mol Vis 13: 2142-2147, 2007. (Pubitemid 350200388)
19. Wang XL, Sim AS, Badenhop RF, McCredie RM and Wilcken DE: A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2: 41-45, 1996. (Pubitemid 26028071)
20. Markus HS, Ruigrok Y, Ali N and Powell JF: Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid athroma. Stroke 29: 1908-1911, 1998.
21. Lembo G, De Luca N, Battagli C, Iovino G, Aretini A, Musicco M, Frati G, Pompeo F, Vecchione C and Trimarco B: A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 32: 735-740, 2001. (Pubitemid 32208729)
22. Szolnoki Z, Havasi V, Bene J, Komlósi K, Szöke D, Somogyvári F, Kondacs A, Szabó M, Fodor L, Bodor A, Gáti I, Wittman I and Melegh B: Endothelial nitric oxide synthase gene interactions and the risk of ischemic stroke. Acta Neurol Scand 111: 29-33, 2005.
23. Notsu Y, Nabika T, Park HY, Masuda J and Kobayashi S: Evaluation of genetic risk factors for silent brain infarction. Stroke 30: 1881-1886, 1999.
24. Kohara K, Fujisawa M, Ando F, Tabara Y, Niino N, Miki T and Shimokata H: MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA Study. Stroke 34: 1130-1135, 2003. (Pubitemid 36547502)
25. Hong SH, Park HM, Ahn JY, Kim OJ, Hwang TS, Oh D and Kim NK: ACE I/D polymorphism in Korean patients with ischemic stroke and silent brain infarction. Acta Neurol Scand 117: 244-249, 2008. (Pubitemid 351361955)
26. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr and Roccella EJ: The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289: 2560-2572, 2003. (Pubitemid 37430158)
27. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 27: S5-S9, 2004.
28. Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG and Marsden PA: Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Artheroscler Thromb Vasc Biol 17: 2479-2488, 1997. (Pubitemid 28015984)
29. Van Rijn MJ, Bos MJ, Isaacs A, Yazdanpanah M, Arias-Vásquez A, Stricker BH, Klungel OH, Oostra BA, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM and van Duijn CM: Polymorphisms of the renin-angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology. J Neurol Neurosurg Psychiatry 78: 1083-1087, 2007.